In-Silico Drug Discovery-Global Market Status and Trend Report 2016-2026

Table of Contents

Chapter 1 Overview of In-Silico Drug Discovery

• 1.1 Definition of In-Silico Drug Discovery in This Report
• 1.2 Commercial Types of In-Silico Drug Discovery
  • 1.2.1 Software as a Service (Cloud)
  • 1.2.2 Consultancy as a Service
  • 1.2.3 Software
• 1.3 Downstream Application of In-Silico Drug Discovery
  • 1.3.1 Contract Research Organization
  • 1.3.2 Pharmaceutical Industry
  • 1.3.3 Academic and Research Institutes
  • 1.3.4 Others
• 1.4 Development History of In-Silico Drug Discovery
• 1.5 Market Status and Trend of In-Silico Drug Discovery 2016-2026
  • 1.5.1 Global In-Silico Drug Discovery Market Status and Trend 2016-2026
  • 1.5.2 Regional In-Silico Drug Discovery Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of In-Silico Drug Discovery 2016-2021
• 2.2 Production Market of In-Silico Drug Discovery by Regions
  • 2.2.1 Production Volume of In-Silico Drug Discovery by Regions
  • 2.2.2 Production Value of In-Silico Drug Discovery by Regions
• 2.3 Demand Market of In-Silico Drug Discovery by Regions
• 2.4 Production and Demand Status of In-Silico Drug Discovery by Regions
  • 2.4.1 Production and Demand Status of In-Silico Drug Discovery by Regions 2016-2021
  • 2.4.2 Import and Export Status of In-Silico Drug Discovery by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of In-Silico Drug Discovery by Types
• 3.2 Production Value of In-Silico Drug Discovery by Types
• 3.3 Market Forecast of In-Silico Drug Discovery by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of In-Silico Drug Discovery by Downstream Industry
• 4.2 Market Forecast of In-Silico Drug Discovery by Downstream Industry

Chapter 5 Market Driving Factor Analysis of In-Silico Drug Discovery

• 5.1 Global Economy Situation and Trend Overview
• 5.2 In-Silico Drug Discovery Downstream Industry Situation and Trend Overview

Chapter 6 In-Silico Drug Discovery Market Competition Status by Major Manufacturers

• 6.1 Production Volume of In-Silico Drug Discovery by Major Manufacturers
• 6.2 Production Value of In-Silico Drug Discovery by Major Manufacturers
• 6.3 Basic Information of In-Silico Drug Discovery by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of In-Silico Drug Discovery Major Manufacturer
  • 6.3.2 Employees and Revenue Level of In-Silico Drug Discovery Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 In-Silico Drug Discovery Major Manufacturers Introduction and Market Data

• 7.1 Charles River
  • 7.1.1 Company profile
  • 7.1.2 Representative In-Silico Drug Discovery Product
  • 7.1.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Charles River
• 7.2 Certara USA, Inc.
  • 7.2.1 Company profile
  • 7.2.2 Representative In-Silico Drug Discovery Product
  • 7.2.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Certara USA, Inc.
• 7.3 Evotec
  • 7.3.1 Company profile
  • 7.3.2 Representative In-Silico Drug Discovery Product
  • 7.3.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Evotec
• 7.4 Dassault System (Biovia)
  • 7.4.1 Company profile
  • 7.4.2 Representative In-Silico Drug Discovery Product
  • 7.4.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Dassault System (Biovia)
• 7.5 Albany Molecular Research Inc. (AMRI)
  • 7.5.1 Company profile
  • 7.5.2 Representative In-Silico Drug Discovery Product
  • 7.5.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Albany Molecular Research Inc. (AMRI)
• 7.6 Selvita
  • 7.6.1 Company profile
  • 7.6.2 Representative In-Silico Drug Discovery Product
  • 7.6.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Selvita
• 7.7 Schrödinger, Inc.
  • 7.7.1 Company profile
  • 7.7.2 Representative In-Silico Drug Discovery Product
  • 7.7.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Schrödinger, Inc.
• 7.8 GVK BIO
  • 7.8.1 Company profile
  • 7.8.2 Representative In-Silico Drug Discovery Product
  • 7.8.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of GVK BIO
• 7.9 OpenEye Scientific Software
  • 7.9.1 Company profile
  • 7.9.2 Representative In-Silico Drug Discovery Product
  • 7.9.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of OpenEye Scientific Software
• 7.10 Chemical Computing Group (CCG)
  • 7.10.1 Company profile
  • 7.10.2 Representative In-Silico Drug Discovery Product
  • 7.10.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Chemical Computing Group (CCG)

Chapter 8 Upstream and Downstream Market Analysis of In-Silico Drug Discovery

• 8.1 Industry Chain of In-Silico Drug Discovery
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of In-Silico Drug Discovery

• 9.1 Cost Structure Analysis of In-Silico Drug Discovery
• 9.2 Raw Materials Cost Analysis of In-Silico Drug Discovery
• 9.3 Labor Cost Analysis of In-Silico Drug Discovery
• 9.4 Manufacturing Expenses Analysis of In-Silico Drug Discovery

Chapter 10 Marketing Status Analysis of In-Silico Drug Discovery

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources